Precision Historical Income Statement
| DTIL Stock | USD 11.51 1.36 10.57% |
Historical analysis of Precision BioSciences income statement accounts such as Selling General Administrative of 29 M or Total Revenue of 35.8 M can show how well Precision BioSciences performed in making a profits. Evaluating Precision BioSciences income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Precision BioSciences's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Precision BioSciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Precision BioSciences is a good buy for the upcoming year.
Precision |
About Precision Income Statement Analysis
Precision BioSciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Precision BioSciences shareholders. The income statement also shows Precision investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Precision BioSciences Income Statement Chart
Precision BioSciences Income Statement is one of the three primary financial statements used for reporting Precision's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Precision BioSciences revenue and expense. Precision BioSciences Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Precision BioSciences' Income Tax Expense is quite stable compared to the past year. Net Interest Income is expected to rise to about 5.9 M this year, although the value of Total Revenue will most likely fall to about 35.8 M. Add Fundamental
Total Revenue
Total revenue comprises all receipts Precision BioSciences generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Precision BioSciences minus its cost of goods sold. It is profit before Precision BioSciences operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Most accounts from Precision BioSciences' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Precision BioSciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Precision BioSciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.At this time, Precision BioSciences' Income Tax Expense is quite stable compared to the past year. Net Interest Income is expected to rise to about 5.9 M this year, although the value of Total Revenue will most likely fall to about 35.8 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 115.5M | 16.1M | 40.5M | 33.4M | Total Revenue | 115.5M | 25.1M | 48.7M | 35.8M |
Precision BioSciences income statement Correlations
Click cells to compare fundamentals
Precision BioSciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Precision BioSciences income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Income | 4.3M | 822K | 208K | 3.5M | 7.8M | 8.2M | |
| Interest Expense | 182K | 822K | 132K | 1.1M | 2.2M | 2.3M | |
| Selling General Administrative | 27.0M | 36.1M | 39.7M | 41.5M | 39.1M | 29.0M | |
| Total Revenue | 22.2M | 24.3M | 115.5M | 25.1M | 48.7M | 35.8M | |
| Gross Profit | 22.2M | 24.3M | 115.5M | 16.1M | 40.5M | 33.4M | |
| Operating Income | (87.2M) | (109.8M) | (39.4M) | (100.4M) | (43.7M) | (45.9M) | |
| Net Income From Continuing Ops | (92.9M) | (109.0M) | (30.6M) | (111.6M) | (87.2M) | (91.6M) | |
| Ebit | (87.2M) | (109.8M) | (39.4M) | (100.4M) | (43.7M) | (45.9M) | |
| Research Development | 82.4M | 98.1M | 115.2M | 83.9M | 49.4M | 69.3M | |
| Total Operating Expenses | 109.4M | 134.1M | 154.9M | 125.5M | 84.2M | 97.8M | |
| Income Before Tax | (92.9M) | (109.0M) | (30.6M) | (111.6M) | (42.5M) | (44.7M) | |
| Total Other Income Expense Net | (5.7M) | 822K | 8.8M | (11.3M) | 1.2M | 1.3M | |
| Net Income Applicable To Common Shares | (92.9M) | (109.0M) | (30.6M) | (111.6M) | (100.5M) | (95.4M) | |
| Net Income | (83.3M) | (109.0M) | (30.9M) | (122.9M) | (69.8M) | (73.3M) | |
| Income Tax Expense | (9.6M) | (822K) | 316K | 11.3M | 27.2M | 28.6M | |
| Net Interest Income | 4.1M | 822K | 76K | 2.4M | 5.7M | 5.9M | |
| Depreciation And Amortization | (174K) | 10.6M | 10.6M | 1.9M | 8.3M | 5.5M | |
| Other Operating Expenses | 109.4M | 134.1M | 154.9M | 125.5M | 92.5M | 110.6M | |
| Ebitda | (87.4M) | (99.2M) | (28.8M) | (98.5M) | (35.5M) | (37.3M) | |
| Reconciled Depreciation | 5.3M | 9.8M | 10.2M | 9.0M | 9.0M | 7.4M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Precision BioSciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Precision BioSciences' short interest history, or implied volatility extrapolated from Precision BioSciences options trading.
Pair Trading with Precision BioSciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Precision BioSciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Precision BioSciences will appreciate offsetting losses from the drop in the long position's value.Moving against Precision Stock
| 0.41 | PFE | Pfizer Inc Sell-off Trend | PairCorr |
The ability to find closely correlated positions to Precision BioSciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Precision BioSciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Precision BioSciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Precision BioSciences to buy it.
The correlation of Precision BioSciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Precision BioSciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Precision BioSciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Precision BioSciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Precision BioSciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for Precision Stock analysis
When running Precision BioSciences' price analysis, check to measure Precision BioSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Precision BioSciences is operating at the current time. Most of Precision BioSciences' value examination focuses on studying past and present price action to predict the probability of Precision BioSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Precision BioSciences' price. Additionally, you may evaluate how the addition of Precision BioSciences to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |
Is Precision BioSciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precision BioSciences. If investors know Precision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precision BioSciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (332.12) | Revenue Per Share 12.685 | Quarterly Revenue Growth (0.34) | Return On Assets (0.14) | Return On Equity (1.07) |
The market value of Precision BioSciences is measured differently than its book value, which is the value of Precision that is recorded on the company's balance sheet. Investors also form their own opinion of Precision BioSciences' value that differs from its market value or its book value, called intrinsic value, which is Precision BioSciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precision BioSciences' market value can be influenced by many factors that don't directly affect Precision BioSciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Precision BioSciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Precision BioSciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precision BioSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.